Global Animal Antibiotics and Antimicrobials Market
Global Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Comprehensive Study by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins, Other), Application (Food-producing Animals, Companion Animals), Mode of Delivery (Premixes, Oral Powder, Injection) Players and Region - Global Market Outlook to 2024

Animal Antibiotics and Antimicrobials Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 239 Pages 190 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Animal Antibiotics and Antimicrobials Market Scope
Increasing demand for pet insurance, rising animal health spending and Growing demand for animal-derived food products will help to fuel Animal Antibiotics and Antimicrobials in the forecasted period. Animal antibiotics and antimicrobials can be used in those animals which contribute to the development of antimicrobial resistance in bacteria that may be transmitted to persons, there for it decreases the efficiency of antimicrobial drugs for handling the human disease. Growing initiatives regarding animal health and welfare are anticipated to support the whole global market for animal antimicrobials and antibiotics.

The market study is being classified by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins and Other), by Application (Food-producing Animals and Companion Animals) and major geographies with country level break-up.

Research Analyst at AMA predicts that United States and Europeam Players will contribute to the maximum growth of Global Animal Antibiotics and Antimicrobials market throughout the predicted period.

Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Eli Lilly and Company (United States), Virbac (France), Zoetis, Inc. (United States), Bayer AG (Germany), Merck & Co., Inc. (United States), Eli Lilly and Company (United States) and Virbac (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France) and Dechra Pharmaceuticals PLC (United Kingdom).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Animal Antibiotics and Antimicrobials market by Type, Application and Region.

On the basis of geography, the market of Animal Antibiotics and Antimicrobials has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Mode of Delivery, the sub-segment i.e. Premixes will boost the Animal Antibiotics and Antimicrobials market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Rising Instances of Zoonotic Diseases will further Increase the Adoption
  • Continues Increase in Animal Health Expenditure

Market Drivers
  • Increasing Demand for Food Products Derived from Animals
  • Favorable Government Regulations in Preventing the Spread of Animal Diseases

Opportunities
  • Upsurging Demand from the Untapped Emerging Economies
  • Robustly Growing Population for Companion Animals may further Increase the Demand

Restraints
  • Growing Threat of Substitutes such as New Antibiotics as well as it can be replaced by Good Husbandry and Hygiene Practices
  • Due to Increased Consumption, Growing Resistance Concerns to Antimicrobials and Antibiotics

Challenges
  • Complex and Lengthy Approval Process for Antimicrobials and Antibiotics


Key Target Audience
Animal Antibiotics and Antimicrobials Manufacturers, Animal Antibiotics and Antimicrobials Distributors and Traders, Upstream and Downstream Buyers, Government Agencies, Healthcare Industry Associations, Venture Capitalist, Animal Based Industry Associations and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Etracyclines
  • Penicillins
  • Macrolides
  • Aminoglycosides
  • Sulfonamides
  • Fluoroquinolones
  • Lincosamides
  • Cephalosporins
  • Other
By Application
  • Food-producing Animals
  • Companion Animals
By Mode of Delivery
  • Premixes
  • Oral Powder
  • Injection

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Food Products Derived from Animals
      • 3.2.2. Favorable Government Regulations in Preventing the Spread of Animal Diseases
    • 3.3. Market Challenges
      • 3.3.1. Complex and Lengthy Approval Process for Antimicrobials and Antibiotics
    • 3.4. Market Trends
      • 3.4.1. Rising Instances of Zoonotic Diseases will further Increase the Adoption
      • 3.4.2. Continues Increase in Animal Health Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Antibiotics and Antimicrobials, by Type, Application, Mode of Delivery and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 5.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 5.2.1.1. Etracyclines
        • 5.2.1.2. Penicillins
        • 5.2.1.3. Macrolides
        • 5.2.1.4. Aminoglycosides
        • 5.2.1.5. Sulfonamides
        • 5.2.1.6. Fluoroquinolones
        • 5.2.1.7. Lincosamides
        • 5.2.1.8. Cephalosporins
        • 5.2.1.9. Other
      • 5.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 5.2.2.1. Food-producing Animals
        • 5.2.2.2. Companion Animals
      • 5.2.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Value)
        • 5.2.3.1. Premixes
        • 5.2.3.2. Oral Powder
        • 5.2.3.3. Injection
      • 5.2.4. Global Animal Antibiotics and Antimicrobials Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Animal Antibiotics and Antimicrobials: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eli Lilly and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck & Co., Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Virbac (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Antibiotics and Antimicrobials Sale, by Type, Application, Mode of Delivery and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 7.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 7.2.1.1. Etracyclines
        • 7.2.1.2. Penicillins
        • 7.2.1.3. Macrolides
        • 7.2.1.4. Aminoglycosides
        • 7.2.1.5. Sulfonamides
        • 7.2.1.6. Fluoroquinolones
        • 7.2.1.7. Lincosamides
        • 7.2.1.8. Cephalosporins
        • 7.2.1.9. Other
      • 7.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 7.2.2.1. Food-producing Animals
        • 7.2.2.2. Companion Animals
      • 7.2.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Value)
        • 7.2.3.1. Premixes
        • 7.2.3.2. Oral Powder
        • 7.2.3.3. Injection
      • 7.2.4. Global Animal Antibiotics and Antimicrobials Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 2. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2013-2018)
  • Table 3. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2013-2018)
  • Table 4. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2013-2018)
  • Table 5. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2013-2018)
  • Table 6. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2013-2018)
  • Table 7. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2013-2018)
  • Table 8. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2013-2018)
  • Table 9. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2013-2018)
  • Table 10. Animal Antibiotics and Antimicrobials Other , by Region USD Million (2013-2018)
  • Table 11. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 12. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2013-2018)
  • Table 13. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2013-2018)
  • Table 14. Animal Antibiotics and Antimicrobials: by Mode of Delivery(USD Million)
  • Table 15. Animal Antibiotics and Antimicrobials Premixes , by Region USD Million (2013-2018)
  • Table 16. Animal Antibiotics and Antimicrobials Oral Powder , by Region USD Million (2013-2018)
  • Table 17. Animal Antibiotics and Antimicrobials Injection , by Region USD Million (2013-2018)
  • Table 18. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 19. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 20. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 21. South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 22. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 23. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 24. Brazil Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 25. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 26. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 27. Argentina Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 28. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 29. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 30. Rest of South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 31. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 32. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 33. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 34. Asia Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 35. China Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 36. China Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 37. China Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 38. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 39. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 40. Japan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 41. India Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 42. India Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 43. India Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 44. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 45. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 46. South Korea Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 47. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 48. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 49. Taiwan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 50. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 51. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 52. Australia Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 56. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 57. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 58. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 59. Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 60. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 61. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 62. Germany Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 63. France Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 64. France Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 65. France Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 66. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 67. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 68. Italy Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 69. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 70. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 71. United Kingdom Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 72. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 73. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 74. Netherlands Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 75. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 76. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 77. Rest of Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 78. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 79. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 80. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 81. MEA Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 82. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 83. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 84. Middle East Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 85. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 86. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 87. Africa Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 88. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 89. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 90. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 91. North America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 92. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 93. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 94. United States Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 95. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 96. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 97. Canada Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 98. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 99. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 100. Mexico Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2013-2018)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 112. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2019-2024)
  • Table 113. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2019-2024)
  • Table 114. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2019-2024)
  • Table 115. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2019-2024)
  • Table 116. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2019-2024)
  • Table 117. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2019-2024)
  • Table 118. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2019-2024)
  • Table 119. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2019-2024)
  • Table 120. Animal Antibiotics and Antimicrobials Other , by Region USD Million (2019-2024)
  • Table 121. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 122. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2019-2024)
  • Table 123. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2019-2024)
  • Table 124. Animal Antibiotics and Antimicrobials: by Mode of Delivery(USD Million)
  • Table 125. Animal Antibiotics and Antimicrobials Premixes , by Region USD Million (2019-2024)
  • Table 126. Animal Antibiotics and Antimicrobials Oral Powder , by Region USD Million (2019-2024)
  • Table 127. Animal Antibiotics and Antimicrobials Injection , by Region USD Million (2019-2024)
  • Table 128. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 129. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 130. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 131. South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 132. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 133. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 134. Brazil Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 135. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 136. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 137. Argentina Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 138. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 139. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 140. Rest of South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 141. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 142. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 143. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 144. Asia Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 145. China Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 146. China Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 147. China Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 148. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 149. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 150. Japan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 151. India Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 152. India Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 153. India Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 154. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 155. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 156. South Korea Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 157. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 158. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 159. Taiwan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 160. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 161. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 162. Australia Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 164. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 165. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 166. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 167. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 168. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 169. Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 170. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 171. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 172. Germany Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 173. France Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 174. France Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 175. France Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 176. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 177. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 178. Italy Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 179. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 180. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 181. United Kingdom Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 182. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 183. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 184. Netherlands Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 185. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 186. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 187. Rest of Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 188. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 189. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 190. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 191. MEA Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 192. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 193. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 194. Middle East Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 195. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 196. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 197. Africa Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 198. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 199. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 200. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 201. North America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 202. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 203. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 204. United States Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 205. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 206. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 207. Canada Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 208. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 209. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 210. Mexico Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2013-2018)
  • Figure 5. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2013-2018)
  • Figure 6. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery USD Million (2013-2018)
  • Figure 7. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 8. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 9. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 10. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 11. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 12. Global Animal Antibiotics and Antimicrobials share by Players 2018 (%)
  • Figure 13. Global Animal Antibiotics and Antimicrobials share by Players (Top 3) 2018(%)
  • Figure 14. Global Animal Antibiotics and Antimicrobials share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Zoetis, Inc. (United States) Revenue: by Geography 2018
  • Figure 18. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 20. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 22. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 23. Eli Lilly and Company (United States) Revenue: by Geography 2018
  • Figure 24. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 25. Virbac (France) Revenue: by Geography 2018
  • Figure 26. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Zoetis, Inc. (United States) Revenue: by Geography 2018
  • Figure 28. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 30. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 32. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 33. Eli Lilly and Company (United States) Revenue: by Geography 2018
  • Figure 34. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 35. Virbac (France) Revenue: by Geography 2018
  • Figure 36. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2019-2024)
  • Figure 37. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2019-2024)
  • Figure 38. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery USD Million (2019-2024)
  • Figure 39. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 40. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 41. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 42. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 43. North America Animal Antibiotics and Antimicrobials Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Zoetis, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Bayer AG (Germany)
  • Eli Lilly and Company (United States)
  • Virbac (France)
  • Zoetis, Inc. (United States)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (United States)
  • Eli Lilly and Company (United States)
  • Virbac (France)
Additional players considered in the study are as follows:
Boehringer Ingelheim GmbH (Germany) , Ceva Sante Animale (France) , Vetoquinol S.A. (France) , Sanofi (France) , Dechra Pharmaceuticals PLC (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation